Vital Signs #49: H/X, Crowdfunding, Foundations

Venture Philanthropy 

Interest in Venture Philanthropy has risen as a result of Vertex Pharmaceuticals/Cystic Fibrosis Foundation’s successful collaboration on the development and approval of KALYDECO, the first medicine to treat the underlying cause of cystic fibrosis.

This collaboration has paved the way for similar approaches to the development of new medicines in other disease areas. A number of nonprofit/industry collaborations have emerged, among them the Alzheimer’s Drug Discovery Foundation, the Multiple Myeloma Research Foundation, the Myelin Repair Foundation and the Michael J. Fox Foundation. In fact, between 2000 and 2007, there was a 10-fold increase in nonprofit organizations investing in biopharmaceutical medicine development.

 

HealthiosXchange is launching Foundation Place, a Crowdfunding Portal serving the interests of Foundations and emerging growth healthcare companies. Foundation Place is designed to assist Foundations with conducting due diligence and sourcing deal flow while providing healthcare companies a valued platform for interacting with leading non-dilutive financing sources. By joining a global network of successful executives, thought leaders, entrepreneurs and fellow investors, members of the HealthiosXchange ("H/X") become part of an elite group of passionate, intelligent and imaginative individuals searching for both superior returns and a chance to establish a legacy that will have a meaningful impact on the world.

If you are a Foundation seeking search and evaluation support, interested in follow-on capital, and expanding your donor base,  please click here to learn more about H/X.

 

Back to Blog